top of page
WearMe-device-reduced-(1).png

We

Fight

COPD

Learn More About WearMe

Rise Up & Walk

The Problem

The financial burden of Chronic Obstructive Pulmonary disease is Too High. Patients have a 30-day readmission rate of 24%.

Our Solution

Our solution is the world's first wearable multimodal physiological sensing system. Our technology addresses the data gap to reduce hospitalization cost and readmission rates.

Technology

Our wearable solution creates a portfolio of physiological parameters that allow for a comprehensive cardiopulmonary assessment to be used for early symptom identification and treatment.

About Us

Lasarrus

Currently, there are over 16.4 million people in the U.S. who suffer from COPD. Of those, 24% of them will be readmitted to the hospitals due to increased symptoms or severity. At LASARRUS we are creating device-enabled solutions for remote monitoring of Chronic Obstructive Pulmonary Disease (COPD) that is reliable, accurate and easy to use.

  • Facebook
  • LinkedIn

Our Founders.

LASARRUS is founded by four brothers with over 50 years of cumulative professional experience, with each bringing a unique value to the success of the company. 

Our Team.

Our Advisors

AS FEATURED ON

indel_dev.webp
logo_dk.webp
Analog-Devices-800x600-1.png
Terasic_Supplier_Logo.webp
download.png
4ae6e7_fd2690d618cd408f9f17c4ff12562549_mv2_d_4736_3157_s_4_2.webp

We Take Pride In Being The 2018 Intel Design Contest Winners

unnamed.jpg

Intel FPGA Innovation Day

"A master class in FPGA-inspired technology innovation."
Intel_logo_(2006-2020).svg.png

The Possibilities Are Endless